$7.15
-0.01-0.14%
At close: Sep 17, 7:44 PM EDT
$7.14
-0.01-0.14%
After Hours: Sep 17, 7:44 PM EDT
15 minutes delayed
Comments
Loading...
G1 Therapeutics (GTHX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestG1 Therapeutics (NASDAQ:GTHX) Stock Quotes, Forecast and News Summary
G1 Therapeutics Stock (NASDAQ: GTHX) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 2.19M |
| Day Range | - - - |
| 52 Wk Range | 1.08 - 7.19 |
| Market Cap | $376.69M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 83 |
| Short Interest | 6.52% |
| Days to Cover | 2.17 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About G1 Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing nov...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy G1 Therapeutics (GTHX) stock?
You can purchase shares of G1 Therapeutics (NASDAQ:GTHX) through any online brokerage.
Who are G1 Therapeutics (GTHX) competitors?
Other companies in G1 Therapeutics’s space includes: Valneva (NASDAQ:VALN), Inozyme Pharma (NASDAQ:INZY), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO) and Larimar Therapeutics (NASDAQ:LRMR).
What is the forecast, or price target, for G1 Therapeutics (GTHX) stock?
G1 Therapeutics has a consensus price target of $8.50.
What is the current price for G1 Therapeutics (GTHX)?
The stock price for G1 Therapeutics (NASDAQ: GTHX) is $7.14 last updated September 17, 2024 at 7:44 PM EDT.
Does G1 Therapeutics (GTHX) pay a dividend?
There are no upcoming dividends for G1 Therapeutics.
When is G1 Therapeutics (NASDAQ:GTHX) reporting earnings?
G1 Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
Is G1 Therapeutics (GTHX) going to split?
There is no upcoming split for G1 Therapeutics.
What sector and industry does G1 Therapeutics (GTHX) operate in?
G1 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.